Log in

NASDAQ:NBIXNeurocrine Biosciences Earnings Date, Estimates & History

$124.80
+3.63 (+3.00 %)
(As of 05/25/2020 02:19 PM ET)
Add
Compare
Today's Range
$120.14
Now: $124.80▼
$124.89
50-Day Range
$85.09
MA: $101.58▼
$124.41
52-Week Range
$72.14
Now: $124.80▼
$127.28
Volume639,862 shs
Average Volume905,278 shs
Market Capitalization$11.59 billion
P/E Ratio67.83
Dividend YieldN/A
Beta1.26

Earnings

Neurocrine Biosciences (NASDAQ:NBIX) Earnings Information

Neurocrine Biosciences last released its earnings results on May 6th, 2020. The reported $0.82 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.26. The company had revenue of $237.10 million for the quarter, compared to the consensus estimate of $226.29 million. Its revenue for the quarter was up 71.3% on a year-over-year basis. Neurocrine Biosciences has generated $0.39 earnings per share over the last year and currently has a price-to-earnings ratio of 67.8. Neurocrine Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 3rd, 2020 based off prior year's report dates.

Neurocrine Biosciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Neurocrine Biosciences (NASDAQ:NBIX) Earnings Estimates

2020 EPS Consensus Estimate: $2.95
2021 EPS Consensus Estimate: $4.72
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20206$0.52$0.63$0.57
Q2 20206$0.32$0.94$0.71
Q3 20206$0.35$1.32$0.93
Q4 20206$0.43$1.11$0.74
Q1 20212$0.61$1.23$0.92
Q2 20212$0.82$1.46$1.14
Q3 20212$1.11$1.67$1.39
Q4 20211$1.27$1.27$1.27

Neurocrine Biosciences (NASDAQ NBIX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/3/2020
(Estimated)		       
5/6/20203/31/2020$0.56$0.82$1.25$226.29 million$237.10 millionTranscript
2/4/2020Q4 19$0.75$0.35$0.35$231.54 million$244.10 millionTranscript
11/4/2019Q3 2019$0.63$0.56$1.02$211.31 million$222.09 millionTranscript
7/29/2019Q2$0.24$0.37$0.20$161.79 million$183.58 millionTranscript
4/29/20193/31/2019($1.05)($1.12)($1.12)$136.77 million$138.40 millionListen
2/5/201912/31/2018$0.14$0.19$0.19$132.32 million$131.49 millionN/A
11/5/20189/30/2018$0.48$0.52$0.52$151.51 million$151.80 millionTranscript
7/31/2018Q2 2018($0.18)($0.07)($0.07)$84.11 million$96.90 millionN/A
4/30/2018Q1 2018($0.29)($0.47)($0.47)$65.17 million$71.08 millionTranscript
2/13/2018Q4 2017$0.18$0.07$0.07$94.00 million$94.52 millionTranscript
11/1/2017Q3 2017($0.49)($0.13)($0.13)$29.38 million$60.77 millionN/A
8/3/2017Q2 17($0.67)($0.68)($0.68)$0.61 million$6.34 millionListen
5/9/2017Q1 17($0.67)($0.90)($0.90)$3.00 millionListen
2/14/2017Q416($0.55)($0.51)($0.51)$4.55 millionListen
11/2/2016Q316($0.57)($0.43)($0.43)N/A
8/3/2016Q2 2016($0.50)($0.46)($0.46)N/A
5/5/2016Q1($0.29)($0.22)($0.22)$15.43 million$15.00 millionN/A
2/11/2016Q415($0.32)($0.34)($0.34)$3.33 millionListen
10/29/2015Q315($0.25)($0.40)($0.40)$6.66 millionListen
7/29/2015Q2($0.2860)($0.28)($0.28)$0.41 millionListen
4/30/2015Q115($0.30)($0.01)($0.01)$19.76 millionN/A
2/9/2015Q414($0.24)($0.26)($0.26)N/A
11/3/2014Q314($0.21)($0.21)($0.21)N/A
8/6/2014Q214($0.18)($0.18)($0.18)$0.12 millionTranscript
4/30/2014Q114($0.19)($0.17)($0.17)$0.78 millionListen
2/6/2014Q4 2013($0.17)($0.16)($0.16)$0.79 million$0.73 millionN/A
10/29/2013Q3 2013($0.20)($0.17)($0.17)$0.79 million$0.73 millionTranscript
7/25/2013Q2 2013($0.20)($0.18)($0.18)$0.77 million$0.73 millionListen
5/2/2013Q1 2013($0.18)($0.18)($0.18)$1.07 million$0.70 millionListen
2/8/2013Q4 2012($0.08)$0.14$9.43 million$21.90 millionListen
10/31/2012Q312($0.05)($0.05)$10.28 million$9.40 millionN/A
7/31/2012($0.03)($0.01)N/A
5/2/2012($0.01)Listen
2/8/2012Q4 2011$0.01$0.02$0.02N/A
10/31/2011$0.19$0.56Transcript
7/28/2011$0.04$0.04N/A
5/3/2011$0.05$0.05N/A
2/10/2011$0.04$0.05N/A
10/28/2010Q3 2010$0.05$0.06$0.06N/A
7/28/2010Q2 2010($0.17)($0.09)($0.09)N/A
4/28/2010Q1 2010($0.24)($0.20)($0.21)N/A
2/3/2010Q4 2009($0.28)($0.22)($0.24)N/A
10/28/2009Q3 2009($0.35)($0.21)($0.21)N/A
7/29/2009Q2 2009($0.41)($0.37)($0.35)N/A
5/5/2009Q1 2009($0.38)($0.38)($0.25)N/A
2/3/2009Q4 2008($0.47)($0.75)($0.75)N/A
10/28/2008Q3 2008($0.52)($0.46)($0.46)N/A
7/30/2008Q2 2008($0.52)($0.55)($0.55)N/A
4/30/2008Q1 2008($0.54)($0.55)($0.55)N/A
2/5/2008Q4 2007($0.84)($0.71)$1.93N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/25/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.